We have examined the timing of specification of the pronephric tubules and duct in Xenopus laevis by explanting the presumptive pronephric rudiments into blastula ectodermal wraps. We have established the time point of specification using the monoclonal antibody markers 3G8 and 4A6 which recognize antigens in pronephric tubule and duct, respectively. We show that, by experimental analysis in explants, kidney tubules are specified by stage 12.5 in the pronephric anlagen whereas pronephric duct is specified later between stages 13 and 14. Furthermore we show that signals involved in tubulogenesis of the pronephric tubules are normally received between stage 12.5 and 13. These experiments unambiguously pinpoint the timing of pronephros specification analyzed by explant experimentation to a developmental stage prior to that demonstrated for urodele amphibia, and provide an essential biological backdrop to a search for the molecular nature of pronephric inducers.
Introduction
Vertebrates use a succession of different kidney forms to control water loss and excrete waste through embryonic and adult life. These kidney forms, the pronephros, mesonephros and metanephros, develop from intermediate mesoderm following a precise temporal and spatial sequence, each kidney being formed as a result of an inductive interaction with the previous form (Burns, 1955; Hertzlinger, 1995) .The pronephros is vestigial in amniotes, but is the fully functional embryonic kidney in lower vertebrates. The mesonephros is the functional embryonic kidney in higher vertebrates and the functional adult kidney in amphibia and fish. In higher vertebrates the metanephros is the functional adult kidney (reviewed in Saxén, 1987) . All three vertebrate kidneys consist of a basic functional unit, the nephron, but differ with respect to the number and organization of the nephroi within the kidney (reviewed in Saxén, 1987; Vize et al., 1997) The embryonic kidney of the amphibian Xenopus laevis, the pronephros, is in the form of a single non-integrated nephron. The pronephros, which is a paired organ, consists of three functional units, the glomus, the pronephric tubules and the pronephric duct (Nieuwkoop and Faber, 1994) . The single vascularized glomus filters waste from the blood into the coelom. In anuran amphibia, three ciliated nephrostomes link the coelomic cavity to the pronephric tubules, and collect the waste in the coelomic fluid. The cilia within the nephrostomes drive the coelomic fluid containing waste products into the pronephric tubules where nutrients and water are absorbed from the coelomic fluid, and the waste products are transported into the pronephric duct for secretion (see Fox, 1963; Saxén, 1987; Vize et al., 1997 ; for reviews).
The simplicity of the pronephros and the accessibility of the anlagen in Xenopus embryos make this developmental system an attractive organism for the study of kidney organogenesis. A considerable number of molecular markers are now available which distinguish different components of the pronephros (reviewed in Vize et al., 1997) . In particular we have generated monoclonal antibody markers 3G8 and 4A6 which reliably and specifically identify pronephric tubules and duct, respectively, in isolated explants containing pronephric tissue, and in dissected embryos stained as wholemounts (Vize et al., 1995) . These are currently the best characterized markers for pronephros duct and tubule which unambiguously identify these separate differentiated tissues in a totally tissue-specific manner.
The development of the pronephros has recently been revisited with the availability of these molecular markers. Antibody 3G8 recognizes tubules and nephrostomes of the pronephros but not the duct or glomus from stage 31, whereas antibody 4A6 stains only the duct from stage 38. (Vize et al., 1995) . A molecular marker for the glomus, Xenopus Wilms' tumour supressor gene xWT1 has also been identified, (Carroll and Vize, 1996) . Expression of xWT1 is restricted to the developing nephric system in the glomus from tailbud stages. In later embryos this gene is also expressed in the heart. These reagents allow positive identification of these three intermediate mesoderm derivatives and in the case of the antibody markers, probably identify terminal differentiation products of pronephric tissue since their antigens are expressed at some time after the formation of pronephric structures. However, the expression of these antigens is not dependent on the pronephros being of normal morphology in the complete embryo, and so they can be used as reagents to identify pronephric development in growth factor induced explants and in Holtfreter sandwiches. These antibody markers have been used to investigate the interaction of the anlage of the tubules and the duct, and have shown that, as in urodeles, Xenopus is unable to compensate for the division of the pronephric field by micro dissection (Vize et al., 1995) . In anterior/posterior kidney field dissections, duct tissue is rarely found without some associated tubule tissue. Before stage 20 no duct alone explants were found. In dorsal/ventral anlage dissections, at all stages tested, duct was found alone in only the ventral dissections. These data indicated that specification of the primordia of either duct or tubules varies during neurula stages, a result consistent with those data obtained in urodeles (O'Connor, 1938; Holtfreter, 1944) .
In this paper we have examined the timing of specification of the pronephric tubules and duct by explanting the presumptive pronephric rudiments from successively earlier embryos into ectodermal wraps consisting of blastula ectoderm. We have established, utilising explant experiments, at exactly what time point pronephric kidney duct and tubule specification occurs using the molecular marker 3G8, which recognises an antigen in pronephric tubules, and 4A6 which recognises an antigen in pronephric duct. These antibody markers were used to the exclusion of other markers since they are the best characterised, currently available molecular markers which allow the independent identification of tubules and duct respectively. We show that, in an explant experimental study, kidney tubules are specified by stage 12.5 in the pronephric anlagen whereas pronephric duct is specified later, between stages 13 and 14. Furthermore we show that signals involved in tubulogenesis of the pronephric tubules are normally received between stage 12.5 and 13. These experiments unambiguously demonstrate for the first time an accurate time point for the inductive events which give rise to the pronephric kidney primordium, and provide a platform from which to establish the molecular nature of molecules involved in induction and patterning of the pronephros.
Results

Specification of pronephric tubules within an explant culture system
A tissue may be said to be specified when it is capable of forming a given tissue when cultured in a neutral environment (Slack, 1991) . Explants of developing pronephric tubule, pronephric tubule anlagen or presumptive pronephric tubule mesoderm were placed within the 'neutral' environment of two animal caps which, when allowed to heal together, form a stable environment in which the explant can be cultured (see Fig. 1 and Section 4 for a description of the dissection performed). Explants were cultured until equivalent to Nieuwkoop and Faber stage 37/38. The formation of pronephric tubule tissue from the explant within the ectodermal wrap was then analysed by wholemount Fig. 1 . Dissection of explants and subsequent assay for presence of pronephric components. (A) Construction of an ectodermal wrap containing presumptive pronephric tissue. The developing pronephros/pronephric anlagen/presumptive pronephric mesoderm (B) was removed from a donor embryo at a given stage and placed between two stage 9 animal caps. After approximately 15 min to allow healing the explant was placed into 50% Barths saline containing antibiotics and cultured to an appropriate stage. Explants were subsequently wholemount immunostained with monoclonal antibody markers to assay for the presence of pronephric components within the ectodermal wraps. (B) Region of mesoderm explanted from different example stages of donor embryo. (Diagrams of stage 13, 14 and 26 embryos adapted from Nieuwkoop and Faber, 1994.) immunostaining using the pronephric tubule specific monoclonal antibody 3G8, fully characterised in Vize et al. (1995) . 3G8 first binds to the developing tubules at stage 31. This staining pattern expands concurrently with the expansion of the lumen of the tubules, along which the staining is localised. At stage 34, when the pronephros is potentially functional, 3G8 staining occurs in both pronephroi along the length of the tubule present. Fig. 2A shows the immunolocalisation of 3G8 to a stage 37/38 embryo, visualised using an FITC-conjugated secondary antibody. The immunostained ectodermal wraps, containing presumptive pronephric material from donor embryos of stages 32-12, were observed using epifluorescence microscopy. Fig.  2B shows an example of 3G8 positive pronephric tubule tissue that has developed within an ectodermal wrap consisting of stage 16 presumptive pronephric mesoderm sandwiched between stage 9 animal cap tissue and allowed to develop until stage 38 equivalent.
In order to determine the timing of specification of the pronephric tubules, explants were removed from donor embryos from stage 32 to stage 12, to establish when 3G8 positive material no longer differentiated within the explant. The precise explant removed depended on the stage of donor embryo and was related to the extent of pronephric development at that stage, see Section 4 and Fig. 1B .
Observation of ectodermal wraps containing explants from increasingly early stages of donor embryo revealed that presumptive pronephric tissue from stages 12.5 and above clearly expressed 3G8 on culturing in ectodermal wraps (Fig. 2B,C) . The numerical results of these tubule specification assays are shown in Table 1 and Fig. 3 . 3G8-expressing tissue is present in explants from stage 14 and above, and in middle and posterior explants from stage 13 and 12.5 (see Table 1 and Fig. 3 ). Therefore our data suggest that explants from embryos of stage 12.5 and above are specified to form pronephric tubules. In contrast anterior explants from stage 13 and 12.5, or stage 12 anterior, middle or posterior explants are negative (see Table 1 and Fig. 3 ). Explants from stage 12 embryos are therefore not specified to form pronephric tubules. Stage 12 and anterior stage 12.5 explants which contain intermediate mesoderm, but did not form pronephros, acted as internal controls demonstrating that all intermediate mesoderm did not differentiate into pronephros in the culture conditions. These data, based on our findings with these two monoclonal antibodies, clearly suggest that specification of the pronephric tubules occurs between stages 12 and 12.5.
Explants removed from stage 13 or above showed 3G8-expressing tissue in the characteristic tubular form of normal pronephric tubules (Fig. 2B) . In contrast when explants were removed from stage 12.5 donor embryos, the pronephric tubule tissue expressing 3G8 consisted of random epithelial sheets of terminally differentiated tubule epithelium, with no apparent structure (see Fig. 2C ). These data suggest that tissue from stage 12.5 donors had not received, or was not competent to respond to, the signal for these epithelia to undergo tubulogenesis. In contrast, those explants removed from donor embryos of stage 13 or above have received and responded to a signal(s) inducing tubulogenesis. Therefore, we believe that these experiments suggest that there is a ppm, presumptive pronephric mesoderm. Fig. 3 . The timing of specification of pronephric tubules. Explants of developing pronephric tubules/pronephric anlagen/presumptive pronephric mesoderm were removed from progressively earlier stages of donor embryo. These explants were cultured in ectodermal wraps and immunostained with 3G8 and a FITC-conjugated secondary antibody. The data obtained is shown in Tables 1 and 2 and is also displayed graphically. It is clearly shown that tissue explants have been specified to form pronephric tubules at stage 14, and middle/posterior explants have been specified at stage 13 and 12.5. However no tissue is specified to form pronephric tubules in anterior explants at stage 13 or 12.5, and in neither anterior, middle or posterior explants at stage 12. Specification of tubules therefore occurs between stages 12 and 12.5. Lineage labelled embryos were injected with 100 ng of FLDX, subsequent immunostaining was with a TRITC-conjugated secondary antibody. A, anterior; M, middle; P, posterior.
signal(s) that acts between stages 12.5 and 13 to induce tubulogenesis of pronephric tubule epithelium.
To confirm that the correct pronephric region was being excised in each case, donor embryos from stages 12, 12.5 and 13 from which the pronephric primordia used in grafting were excised, were allowed to develop to stage 38 and wholemount immunostained to check that the pronephric rudiment had been removed as a result of the grafting procedure. These embryos showed either partial or complete unilateral pronephric loss, demonstrating that the correct region had been excised.
Specification of pronephric tubules with lineage labelled donor embryos
It can be seen from Table 1 and Fig. 3 that tissue from presumptive pronephric donor tissue does not always form 3G8-expressing tissue within an ectodermal wrap even though it has been isolated from stages know to be specified. Either the explanted tissue was extruded from the wrap during the culture period, as was occasionally observed, or the explanted tissue died during culture before it was equivalent to stage 37/38, and may not have expressed 3G8 for that reason. To try and determine which of these possibilities was correct, and more importantly to confirm that wraps containing tissue explants from stage 12 embryos were not yet specified, lineage labelled donor embryos were used. Embryos were lineage labelled with FLDX by injection bilaterally at the two-cell stage (see Section 4). The presence of explanted fluorescent donor tissue within the ectodermal wrap could therefore be confirmed. Table 2 and Fig. 3 show that when FLDX-lineage labelled tissue is present within an ectodermal wrap after culture and immunostaining, 3G8-expressing tissue is not always found. It therefore appears that in these cases the tissue died or failed to develop normally during culture, prior to reaching a stage at which the 3G8 antigen is expressed.
Observation of ectodermal wraps made with FLDX-injected donor tissue also revealed that a proportion of embryos no longer contained presumptive pronephric mesoderm at the time of analysis. Most importantly however, the data obtained with lineage labelled explants mirrored that observed with non-labelled donor embryos. Explants taken from stage 12.5 (middle or posterior regions) or above formed 3G8-expressing pronephric tubule tissue, whereas explants taken from stage 12 embryos did not (Fig. 3) . Thus confirming that the pronephric tubules are specified between stage 12 and 12.5.
Specification of pronephric duct within an explant culture system
In order to establish the timing of specification of the pronephric duct we employed the same explant culture system that was used to establish the specification of the pronephric tubules. Tissue explants of developing pronephric duct, pronephric duct anlagen or presumptive pronephric duct mesoderm were cultured within ectodermal wraps. These ectodermal wraps were produced as described in Fig. 1 and Section 4. Explants were cultured until equivalent to Nieuwkoop and Faber stage 41. The formation of pronephric duct tissue from the explant within the ectodermal wrap was then analysed by wholemount immunostaining using the pronephric duct specific monoclonal antibody 4A6 fully characterised in Vize et al. (1995) . 4A6 first binds the pronephric duct at stage 38. The ducts start to migrate caudally from the pronephric anlage at stage 24, migrating until they reach the rectal diverticula (Nieuwkoop and Faber, 1994) . At stage 38, 4A6 binds to most, but not all, the cells in the duct, with a smaller proportion of cells staining positive at the posterior end (Vize et al., 1995) . Positive staining is seen over the entire surface of those cells that bind 4A6 (Vize et al., 1995) . By stage 41 the duct has retracted as the endoderm and cloaca (of which the rectal diverticula are an anterior extension) have migrated anteriorly, and as a consequence, 4A6 staining is now more dense in posterior regions of the duct (Vize et al., 1995) . Therefore stage 41 was chosen as the stage at which to observe 4A6 expression in tissue explants. Fig. 4A shows the binding of 4A6 to a stage 41 embryo visualised using a TRITC-conjugated secondary antibody. Fig. 4B shows an example of 4A6-positive pronephric duct tissue that has developed within an ectodermal wrap containing stage 14 presumptive pronephric duct. Immunostaining with 4A6 provides a reliable, sensitive and accurate method of distinguishing pronephric duct tissue from that of pronephric tubules. Such identification is difficult by histological criteria (Jaffee, 1954) . To establish the timing of specification of the pronephric duct, explants were removed from progressively earlier stages of donor embryo from stage 39-13. Ectodermal wraps containing these explants were cultured and assayed for the presence of pronephric duct expressing 4A6. There were no differences observed between the structure of 4A6-expressing tissue in explants produced from different stages of donor embryo. The duct forms in either a tubular (see Fig.  4A ) or more 'trumpet-like' form (a tube with one end expanded) irrespective of the stage at which the tissue was explanted. As expected, 4A6 binds the entire surface of positive cells, Fig. 4A ,B.
The numerical results obtained from the specification assay are shown in Tables 3 and 4 and Fig. 5 . Explants removed from embryos of stage 14 and above contained 4A6-expressing pronephric duct tissue. In contrast, stage 13 explants (anterior, middle or posterior) did not contain any 4A6-expressing tissue. These negatively staining explants, together with sandwiches without any grafted mesoderm, demonstrated that neither intermediate mesoderm or ectoderm had any tendency to differentiate into pronephric duct in this assay. Embryos from which grafts had been taken at stage 13 and 14 were allowed to develop until stage 41 and were then immunostained for duct tissue. One hundred percent of these embryos showed either partial or complete unilateral loss of duct structures on the operated side, therefore confirming that the correct region was being excised in each case. This data clearly demonstrates that within this explant culture system pronephric duct is specified between stages 13 and 14.
Specification of pronephric duct with lineage labelled donor tissue
Following the same lines of argument as presented for tubule specification, FLDX lineage labelling was carried out to confirm that negative wraps did contain intermediate mesoderm donor tissue. The results, presented in Table 4 and Fig. 5 confirmed that the pronephric ducts are specified between stages 13 and 14.
Discussion
This work was undertaken with the aim of establishing the timing of specification of the pronephric tubules and pronephric duct of Xenopus laevis. This has been achieved using the explant culture system detailed above. This work . The timing of specification of pronephric duct. Explants of developing pronephric duct/pronephric anlagen/presumptive pronephric mesoderm explants were removed from progressively earlier stages of donor embryo. All explants were then cultured within ectodermal wraps and immunostained with 4A6 and a TRITC-conjugated secondary antibody. The data obtained is shown in Tables 3 and 4 and displayed graphically. It is clearly shown that the grafted tissue has been specified to form pronephric duct at stage 14. Neither anterior, middle nor posterior tissue is specified to form pronephric duct at stage 13. Specification of pronephric duct therefore occurs between stages 13 and 14. Lineage labelled embryos were injected with 100 ng of FLDX, subsequent immunostaining was with a rhodamine-conjugated secondary antibody. A, anterior; M, middle; P, posterior.
has identified the timing of specification of the pronephros in Xenopus to be at an earlier stage of development than was previously accepted for urodele amphibia (Fales, 1935) .
Specification of the pronephric tubules
We have shown that Xenopus pronephric tubules are specified by stage 12.5, late gastrula stage. This is considerably before the pronephric anlagen is first visible at stage 21 (Nieuwkoop and Faber, 1994) . Pronephric tubule tissue, that we believe to be terminally differentiated, can clearly form within presumptive pronephric mesodermal explants removed at stage 12.5. This places the timing of specification at an earlier stage than suggested for the urodele Ambystoma by Fales (1935) . Fales (1935) found that when presumptive pronephric mesoderm, plus overlying ectoderm, were transplanted from a stage 15 embryo orthotopically to the pronephric region of a host embryo or heterotopically to a region within the same embryo below somites 5-9, pronephric tubules formed (to a greater or lesser extent, respectively). Pronephric tubules did not form in transplants taken from earlier stages. In contrast she also found that explants taken from stage 12 embryos placed within the body cavity of older hosts were capable of forming pronephric tubules. However it is hard to compare these results directly with our findings. Not simply because the studies are conducted in different organisms which may or may not adhere to exactly the same developmental schedules, but also the fact that in the study by Fales (1935) it is really the level of determination, rather than specification, of the presumptive pronephric mesoderm that is being investigated. In Fales' experiments the explants are transplanted together with the overlying ectoderm, and are transplanted to a region within a developing embryo. These conditions provide an environment that is far from neutral.
Our experiments are the first to clearly address the question of specification of the pronephric tubules in Xenopus laevis. The nature of the signal that specifies the pronephric tubules and the tissue producing it are currently unknown. At stage 12.5 gastrulation of the Xenopus embryo is almost complete, however the mesodermal mantle is still extending anteriorly. At stage 12 the lateral region of the mesodermal mantle is 40-50°from the animal pole, but by completion of gastrulation at stage 13 it has reached its most anterior destination (Nieuwkoop and Faber, 1994) . During this time the mesoderm is in contact with two other tissue layers: The endoderm migrating in the same direction but at a different rate and the ectoderm migrating in the opposite direction. It may be these interactions between tissue layers that result in the specification of presumptive pronephric mesoderm within the mesodermal mantle. In Xenopus the heart, another mesodermal derivative, is also specified during gastrulation (Sater and Jacobson, 1990) , a process that involves inductive signals from the deep dorsoanterior endoderm (Nascone and Mercola, 1995) . Similar signals may be responsible for the specification of the pronephric tubules. However the tissue(s) involved and the signal(s) they provide in the specification of the presumptive pronephric mesoderm remain to be elucidated.
The molecular mechanisms underlying kidney morphogenesis are still poorly understood despite the identification of a large number of potential candidate regulatory molecules. Transgenic and in vitro culture techniques have identified growth factors, transcription factors, signalling molecules and adhesion molecules with roles in vertebrate kidney development although none of those identified appear to be absolutely necessary, particularly for the initial phases of pronephric kidney development (reviewed in Davies and Brandli, 1996; Lechner and Davies 1997; Vize et al. 1997) .
In amphibia, the homeobox protein Xlim-1 is one of the earliest markers of nephrogenic potential. Expression of Xlim-1 is biphasic, the first phase starting at early gastrula stages (stage 10). A later second peak is associated with cells that will form the pronephros (Taira et al., 1992; Taira et al., 1994) . In gastrula stages the majority of Xlim-1 expression is in the dorsal mesoderm, however, wholemount in situ hybridisations show clear and increasing amounts of this mRNA in lateral mesoderm from stage 13 onwards. This region of increasing expression condenses throughout neurulation to form the developing pronephros (Taira et al., 1994) . Subsequent to tailbud stages this expression of Xlim-1 persists but at a much reduced level, although expression is still detectable in the adult kidney of Xenopus. Interestingly, embryos treated with retinoic acid have an increased level and region of Xlim-1 expression in the lateral mesoderm and form a pronephros that is larger than that of an untreated embryo (Taira et al., 1994) . Xlim-1 is induced in animal caps by treatment with activin. This suggests that this protein may play a role in the high frequency induction of kidney tubules observed by Asashima and ourselves (E.A.J. and H.C.B. unpublished data) in animal caps treated with both activin and retinoic acid (Moriya et al., 1993; Uochi and Asashima, 1996) , although neither activin or retinoic acid alone will induce pronephric tubules. Since our data clearly shows the specification of pronephric tubules at stage 12.5, there is a possibility that Xlim-1 expression is specifying, or is a direct result of the specification of the pronephric tubules.
Tubulogenesis of the specified pronephric tubule epithelium
Explants taken from the middle or posterior regions of stage 12.5 embryos formed 3G8 expressing epithelium, however this epithelial tissue had a random sheet structure. In contrast explants removed from middle or posterior regions of stage 13 donors developed 3G8 expressing tissue that had a tubular structure, similar to the structure of normal pronephric tubules.
This data indicates that in the Xenopus laevis embryo between stages 12.5 and 13 a signal is received by the presumptive tubule tissue that enables it to undergo tubulogenesis. Although the nature of this signal(s) and its origin(s) are unknown there are several potential candidates for the signalling molecule. Several molecules have been identified as having a role in tubulogenesis of the developing mammalian metanephros, through in vitro experimentation. For example Wnt-4 is expressed in the mesonephric and metanephric mesenchyme of the mouse during development. In Wnt-4 homozygous null mutant embryos the metanephric mesenchyme does not differentiate into tubular epithelium. Pre-tubular aggregates rarely form and those that do, do not progress to comma shaped bodies (Stark et al., 1994) . As discussed by Stark and colleagues it is not clear whether Wnt-4 is the inducing signal responsible for tubulogenesis, or is induced as a result of such a signal. EGF, together with an unidentified pituitary extract, have been shown to induce tubulogenesis in uninduced rat metanephric mesenchyme when cultured on a matrix e.g. collagen type IV (Perantoni et al., 1991) , although the effect of EGF may be a purely mitogenic one. In a study by Barros et al. (1995) , HGF (the ligand for c-met), TGFa and EGF have been named as tubulogenic factors when applied to epithelial cell lines grown on a matrix of collagen I. MDCK cells were found to undergo tubulogenesis in response to HGF, though no other factors were tested. In contrast mIMCD-3 cells formed tubular epithelial structures in response to HGF, TGFa or EGF in serum free media, HGF being the most potent inducer of tubulogenesis and EGF the least (Barros et al., 1995) . However it should be noted that these two cell lines are most relevant to the collecting duct epithelia of the metanephric kidney, analogous to the pronephric duct, whereas we have made observations on the timing of tubulogenesis of the pronephric tubules. It is not known which, if any, of the molecules proposed to have a role in tubulogenesis of later kidney forms play a role in inducing the tubulogenesis of specified presumptive pronephric tubule in the Xenopus embryo.
Specification of the pronephric duct
We have also shown in this paper that pronephric duct is specified in Xenopus laevis from stage 14 onwards. The source and nature of the inductive signal responsible for specifying the pronephric duct is not known. The specification of the pronephric tubules occurs prior to the pronephric duct, and in later kidney forms there is a reciprocal interaction between the metanephric mesenchyme (which later forms structures analogous to the pronephric tubules) and the ureteric bud which is an outgrowth of the Wolffian (pronephric) duct. Therefore the pronephric tubules are a candidate as the source of the signal specifying pronephric duct. However, we have shown that the pronephric duct is not specified until stage 14, and Vize and colleagues (Vize et al., 1995) have shown that ventral explants from a stage 12.5 embryo will form ducts without the presence of tubules to specify them. Taken together these data show that the presumptive pronephric tubules are not the source of the signal that specifies the pronephric duct in Xenopus.
To conclude, we have shown that the pronephric tubules and pronephric duct of Xenopus laevis are specified at stages 12.5 and 14, respectively. However it is likely after these initial specification events additional cells are recruited into the pronephric field. Dissections by Vize and colleagues (Vize et al., 1995) showed a changing position of the two specified tissues during development, which they propose is the result of respecification of intermediate mesoderm. The pronephric duct has also been shown to recruit cells along its pathway of caudal migration (Cornish and Etkin, 1993) during normal development. However these later specification events are in addition to the initial events we have shown. We have unambiguously demonstrated, for the first time, the point of specification of the pronephric tubule and pronephric duct in Xenopus laevis.
Experimental procedures
Embryo collection and culturing
Xenopus laevis embryos were obtained by in vitro fertilisation of eggs from females primed with 80iU serum gonadotrophin (Intervet UK) 1-5 days previously and injected with 600iU chorionic gonadotrophin B (Intervet UK 8-16 h prior to the desired laying time. Eggs were collected into Barths saline (88 mM NaCl, 1m M KCl, 24 mM NaHCO 3 , 15 mM Tris-HCl, 0.33 mM Ca(NO 3 ) 2 , 0.41 mM CaCl 2 and 0.8 mM MgS0 4 pH 7.5) and then fertilised by the addition of crushed testis isolated from a sacrificed male. Fertilised eggs were dejellied in 2% cysteine-HCl pH 8.0 (BDH Laboratory Supplies). Embryos were then washed thoroughly and cultured in 10% Barths medium at appropriate temperatures to obtain the stages required (13, 18 or 23°C). Embryos were staged according to Nieuwkoop and Faber (1994) .
Microdissection and explant culture
All manipulations were performed in full strength Barths saline containing 10 mg/ml gentamycin and 5 mg/ml penicillin and streptomycin, on a cushion of 1% agarose in full strength Barths saline. Embryos were manipulated and dissected with watchmakers forceps and an eyebrow hair knife. An explant of developing pronephros/pronephric anlagen/ presumptive pronephric mesoderm was removed from the donor embryo and placed between two animal caps removed from stage 9 embryos (Fig. 1A ). The precise region excised from the donor embryo depended on the stage from which it was isolated (Fig. 1B) , and was related to the extent of pronephric development at that stage, and on whether it was to be used to determine the timing of specification of the pronephric duct or pronephric tubules. In all cases the initial step was to peel away the ectoderm overlying the region of interest. The desired mesodermal explant was then removed.
For pronephric tubules for embryos of stage 21 and above, the developing pronephric tubules only, or pronephric anlagen, were separated from the underlying lateral plate mesoderm. For donor embryos between stages 14 and 20 a region of presumptive pronephric mesoderm was removed from the lateral plate. As shown in Fig. 1B this region is just caudal of the anterior part of the neural plate, and just ventral of the middle part of the neural plate. This is the area in which cells condense to form the pronephric anlagen and later the pronephros (Hausen and Riebesill, 1991) . For donor embryos of stage 13 and below, three regions of lateral plate mesoderm were explanted. The dorsal limit of the mesoderm removed was along a line 35°from the dorsal midline, approximately along the border of the presumptive neural plate. The ventral limit of the mesoderm removed was approximately 15°below this at the anterior end (see Fig. 1B ). The lateral plate mesoderm was separated from the underlying endoderm and subsequently split into anterior, middle and posterior segments, each to be cultured within its own ectodermal wrap.
In experiments analysing pronephric duct specification the regions of tissue explanted at a given stage, and the method of explant removal was as for pronephric tubules for stages 22 and below (see Fig. 1B ). At stages 26, 33/34 and 39 an explant containing the developing tubules and duct was separated from the underlying lateral plate mesoderm. After grafting ectodermal wraps were left undisturbed and allowed to heal for a minimum of 15 min at room temperature. Ectodermal wraps were then transferred to 50% Barths saline containing antibiotics, and cultured to the appropriate stage: stage 37/38 for immunostaining with 3G8 for pronephric tubules; stage 41 for those to be stained with 4A6 for pronephric duct. Explants were fixed in MEMFA (0.1 M MOPS pH 7.4, 2 mM EGTA, 1 mM MgSO4, 3.7% formaldehyde) for 1-2 h at room temperature (or 4°C overnight) then dehydrated in methanol and stored at −20°C until ready for immunostaining. Control wraps were set up for each series of experiments which contained no inserted material. These were consistently negative for both pronephric antibody markers.
Microinjection of lineage label
Embryos at the two-cell stage were placed in 3% ficoll (Sigma) in Barths saline. Each cell of the two-cell stage was then injected with 50 ng of fluorescein lysine dextran (FLDX) (a kind gift of J. Cooke) to give a total concentration of 100 ng per embryo. Several hours after injection embryos were transferred into 10% Barths saline containing antibiotics and cultured to the required stage. Microinjected embryos were then manipulated in the same way as unlabelled embryos, as detailed above.
Wholemount immunostaining
Wholemount immunohistochemistry was performed on embryos and explants fixed in MEMFA and subsequently dehydrated in methanol and stored at −20°C. Both embryo and explant tissue was rehydrated stepwise with phosphate buffered saline (PBS) then blocked with PBT (2 mg/ml bovine serum albumin (Sigma), PBS, 0.2% Tween-20 (BDH Laboratory Supplies) for 1 h at 4°C with end over end rotation on a Stuart blood tube rotator. Undiluted hybridoma supernatant (3G8 or 4A6) was incubated overnight at 4°C with horizontal rotation on a AKA-VIBRAMAX-VXR. Samples were then washed four times with PBT at 4°C with end-over-end rotation, each wash being a minimum of 2 h. A secondary incubation with a 1 in 50 dilution of Goat-anti mouse IgG conjugated to fluorescein isothiocyanate or tetramethylrhodamine isothiocyanate (Sigma), was carried out overnight in the dark at 4°C with horizontal rotation. Samples were washed twice with PBT for 2 h, and once with PBT for 1 h with end-over-end rotation at 4°C. Finally samples were washed in PBS for 1 h to remove any protein that would adhere to the sample on dehydration, with endover-end rotation at 4°C. Samples were then dehydrated with methanol and cleared for at least 15 min with Murrays solution (1:1 benzyl benzoate (Sigma)/benzyl alcohol (BDH Laboratory Supplies)), before mounting in cavity slides and observing and photographing with a Nikon epifluorescence microscope.
